Serum thyroxine binding globulin (TBG) values were correlated with other thyroid function test results and with the clinical condition in 680 patients. The estimation of serum TBG was helpful in the evaluation of thyroid status only in those patients who were either acutely ill, were taking the contraceptive pill, or were pregnant. Further, the derived index, thyroxine: TBG ratio, proved to be a better diagnostic index than the thyroxine: tri-iodothyronine uptake ratio and in many cases would have avoided the use of more expensive and time-consuming tests.
The assays commonly used to detect thyroid dysfunction are a combination of serum thyroxine (T4), tri-iodothyronine uptake (T3-uptake), and free thyroxine index (FT!) as first-line tests, with serum T3, thyroid stimulating hormone (TSH), and the thyrotrophin releasing hormone (TRH) stimulation test to augment the diagnosis. With these tests it is possible to confirm the thyroid status of the majority of patients (Pain and Duncan, 1976; Evered et al., 1978) .
In a proportion of patients, especially those who are on antidepressant therapy, are taking the contraceptive pill, are pregnant, have severe nonthyroidal disease, or are elderly, the above tests become more difficult to interpret because of abnormal levels of the thyroid hormone binding proteins (Oppenheimer, 1968) . The derived index, FIT, was initially reported to compensate for abnormal levels of the thyroxine-binding proteins (Howorth and MacLagen, 1969) , but it has become increasingly recognised that this is not always correct, and reliance on this index may lead to a false diagnosis of thyroid status (Premachandra et al., 1976) . A direct assay of thyroxine binding globulin (TBG) in serum was first described by Freeman and Pearson in 1969, soon followed by the first radioimmunoassay (Levy et al., 1970) . It was the purpose of this study to investigate the relationships of TBG to the other thyroid parameters and to ascertain whether its routine use aids the differentiation of the thyroid disorders.
Patients and methods
Thyroid status was determined using assays of serum 'Present address: Department of Chemical Pathology, Hope Hospital, Eccles Old Road, Salford M6 8HD T4, T 3-uptake, and FT!, followed by assays of serum T3, TSH, or a TRH-stimulation test where appropriate. Details of age, sex, therapy, and clinical diagnosis were recorded at the same time. The patients were then classified as follows:
1 Acutely ill: patients having severe non-thyroidal diseases (eg, congestive cardiac failure, myocardial infarction, severe diabetes, carcinoma, renal failure).
2 Contraceptive pill users: women between the ages of 16 and 40 years who are currently taking any form of oral contraceptive (for periods greater than six months).
3 Pregnant: women between the ages of 16 and 40 years and at between 20 and 40 weeks' of pregnancy. 4 Borderline hypothyroid: patients having either one result in the hypothyroid range or all results outside 75 % of normal limits. 5 Hypothyroid: patients having all results in the hypothyroid range or two out of three results abnormal and the third outside 75 % of normal limits.
6 Hyperthyroid: patients having two out of three results in the hyperthyroid range with the third outside 75 %of normal limits.
7 Euthyroid: patients who are clinically and biochemically normal (using established normal ranges).
Groups 1 to 3 were categorised on clinical findings, while groups 4 to 7 were allocated on biochemical data. Children under 10 years of age and patients who were receiving therapy were not included in this series of 680 patients.
Serum TBG, TSH, and Ts-uptake were assayed using commercially available kits (TBGK-CIS, Eurotope Services Ltd, London; TSH-Imrnophase, Corning Medical, Essex; Thyopac-3-Radiochemical Centre, Amersham). T3 and T4 were assayed by 81 radioimmunoassay methods using a double-antibody and a polyethylene glycol separation respectively. Quality control sera were assayed for each test, and between-batch statistics are shown in Table 1 . Blood samples were obtained by venepuncture; the sera were separated by centrifugation at 2500 rpm for 10 minutes and stored at -20 o e for a maximum of five days before assay. With the exception of Ta-uptake, all assays were performed in duplicate. Table 2 shows the mean value, one standard deviation (SD) value, and 2 SD range for the TBG, Tsuptake, and T4 assays in the seven groups of patients studied, and indicates those groups in which the mean values are statistically significantly different (at the 5 % value) from that of the euthyroid group. It may be observed that, on the basis of the Ts-uptake and T 4 tests, the seven groups are statistically significantly distinct although the range of values overlap to a large extent. The two SD ranges for the Ts-uptake and T4 assays for the euthyroid group correspond closely to the reference ranges employed in this laboratory (92-117 % and 45-145 nmol/l respectively). Similarly, with the exception of the hyperthyroid group, the mean levels of THG in each group are statistically significantly different from the mean level in the euthyroid group.
Results
For the borderline hypothyroid and the hypothyroid groups the wide range of TBG values observed indicates that this assay may be of limited value. Further, TBG levels, along with Ts-uptake David R. McDowell and T4 values, are significantly elevated in the contraceptive and pregnancy groups, and this may cause interpretative problems. It is noteworthy that TBG levels in the 'ill' group are decreased, paralleling the decrease in Ts-uptake and T4 values. Measurement of TBG in these cases appears to be a useful adjunct and helps to distinguish this group from the borderline hypothyroid or the hypothyroid groups.
The TBG levels in each of the seven groups were correlated with the Ts-uptake and T4 data by calculating the constants of the linear regression equation: y = mx + c (where x = serum THG). Table 3 shows the gradient (m), intercept (c), and correlation coefficient (r) with its statistical significance for each group studied. It may be seen that, in each group, TBG levels are well correlated with Ts-uptake values, a not unexpected finding when one considers the physiological basis of the Ts-uptake test.
In contrast, only the euthyroid and the borderline hypothyroid groups show a statistically significant linear correlation between serum TBG and T4 levels. With the exception of the acutely ill group, all groups show an increase in T4 levels with increasing TBG values, probably a physiological response to maintain the free thyroxine at a constant level.
The function, FTI, has been used to allow for binding-protein abnormalities and is purported to approximate the serum free thyroxine level. Similarly, the ratio of T4:TBG should approximate the serum free thyroxine level, and for this reason these two calculated parameters were compared in each group. Methods for the direct measurement of TBG in serum have been known for nine years (Freeman and Pearson, 1969; Levy et al., 1970) and commercial radioimrnunoassays in the United Kingdom for two years. It is the purpose of this study to ascertain whether measurement of serum THG levels provides additional information to supplement the presently available assays of thyroid function. Reference ranges for THG in several distinct clinical groups are shown, and these compare well with previously reported values (Lecureuil et al., 1978) . The overlap in these reference ranges in the clinical groups reflects the continuous spectrum of thyroid disorders. On the basis of these reference ranges, the assay Table 4 shows the mean level, one SD value, and the two SD reference range for each group, and indicates those mean levels that are statistically significantly different (at the 5 %level) from that of the euthyroid group. Although the ranges in the hypothyroid and hyperthyroid groups overlap the euthyroid group, the mean values are statistically significantly distinct. The major finding in this table is that the mean levels of the T4:THG ratio in the contraceptive, pregnant, and acutely ill groups are not statistically significantly different from the mean level in the euthyroid group, whereas for the T4:Ta-uptake ratio the converse is true. Table 5 shows the linear regression parameters for the correlation between the T4:THG ratio and the Ta.Ts-uptake ratio in each of the seven groups studied. In each case there is an excellent positive correlation, emphasising the correlation between Tsuptake and THG levels.
Finally, serum THG levels were compared with serum total protein and total globulin levels. In the group of 100 patients studied, the total protein and total globulin levels were mainly within the normal reference range used in this laboratory, and there was no significant correlation with serum THG levels in either case.
Total protein = 0·18 THG + 68·07 r 0·181 p = not significant.
Total globulin = 0·14 THG + 27·30 r 0·199 P = not significant.
Group

Discussion
T,:TBGv. T.:T,-uptake of serum TBG clearly does not aid the diagnosis of hyperthyroidism. In the borderline hypothyroid and the hypothyroid groups, the mean serum levels of TBG are higher than that of the euthyroid group. The range of values overlaps those of the normal group to such an extent that it seems probable that this finding is also of limited value. In the acutely ill group the reference range for serum TBG is lower than that of the euthyroid group, a finding reflected by the lowered Ts-uptake values. This group often presents a serious diagnostic problem, and patients are often wrongly placed in the borderline hypothyroid or hypothyroid groups (Burger et al., 1976; McLarty et al., 1976; Naeije et al., 1976; Piroska and FOldes, 1976) . T3 and TSH assays and, in some instances, a TRH stimulation test (to diagnose secondary hypothyroidism) are necessary before a correct diagnosis can be established. For this group the measurement of serum TBG is of value and may prevent unnecessary further investigations. In a similar manner the assay is important to detect congenitally increased and decreased levels of TBG. A retrospective examination of the patients studied revealed two decreased levels (less than 6 mg/l) and two increased levels (greater than 50 mg/l), Serum TBG levels are well correlated with T3uptake levels, although at higher values the rate of increase of Ts-uptake with increasing TBG concentration is lowered. This explains why the FTI gives inappropriately elevated levels in patients who are taking the contraceptive pill, are on oestrogen therapy, or are pregnant (Burr et al., 1977) . Clearly, as an indirect assay of TBG, Ts-uptake fails to fulfil this function at high concentrations. If this is a physiological rather than a methodological problem, then the assay of Ts-uptake should be abandoned. If the converse is correct, a modified assay ofTs-uptake, linearly relating T3-uptake values to serum TBG levels over the physiological and pathological ranges, would maintain its position as a first-line test of thyroid function.
Serum TBG levels correlate with T 4 values in the euthyroid and the borderline hypothyroid groups only, although, in the majority of groups, T4 values are increased with increasing TBG levels. (In the 'ill' group the converse is true.) This is probably a physiological response to maintain the free thyroxine at a constant level. The finding of a close correlation between the T 4:T3-uptake ratio and the T 4:TBG ratio is as expected and has been reported elsewhere (Burr et al., 1977; Lecureuil et al., 1978) . The concomitant finding that the T 4:TBG ratio gives values for the ill, contraceptive, and pregnant groups which lie in the euthyroid range, whereas the T4:T 3-uptake ratio gives values in the abnormal range, indicates a further use for the TBG assay. The findings in the David R. McDowell contraceptive and pregnancy groups may be explained by the previously mentioned lowered increase in serum Ts-uptake values in relation to increasing serum TBG concentrations at high levels ofTBG (Burr et al., 1977) . In the acutely ill group the serum levels of TBG are decreased along with those of thyroxine-binding pre-albumin and albumin (increased catabolic state). In this situation the thyroxine-binding pre-albumin and albumin levels become quantitatively more important in relation to TBG levels than in normal circumstances. The T3uptake value is not reduced as much as the TBG level, leading to a relatively higher T4:TBG ratio than T4:T3-uptake ratio. Similarly, the physiological response to maintain the free thyroxine level in these circumstances would explain the negative relationship between T4 and TBG found in the ill group. These findings should be stressed as they provide a means of correctly diagnosing 'non-thyroidal disease' in the three clinically and biochemically ambiguous groups.
The assay of TBG may be performed in five hours at a cost of approximately £0·80 per tube, while T3uptake would take less than an hour at a cost of approximately £0040 per tube and is relatively simpler to perform. Although it appears that on economic and technical grounds TBG is not the superior assay, it is more relevant to consider not the replacement of Ts-uptake by TBG but the use of serum TBG assays to prevent the unnecessary assay of the more expensive and time-consuming TSH, T3, and TRHstimulation tests. It is clear that in many cases there would be savings in time and expense.
The findings in this study suggest that the majority of patients with thyroid dysfunction may be diagnosed by the use of T4 and Ts-uptake with T3 and TSH assays, although there are areas where some interpretative problems may arise. It is in these equivocal areas (a raised serum T4 level with an elevated Ts-uptake value, or lowered serum T4 and Ts-uptake values) where the TBG assay is of value, especially if its use leads to savings in time and expense, prevents the performance of unnecessary assays, and produces a more rapid and reliable diagnostic service. I wish to thank Eurotopc Services Ltd for the supply of the thyroxine binding globulin assay kits.
